Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 6, 2007, Pages 1956-1961

  Heller, Stefanie ^a   Kellenberger, Laurenz ^a   Shapiro, Stuart ^a  

^a BASILEA PHARMACEUTICA INTERNATIONAL LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; BAL 19403; CEFOXITIN; CLINDAMYCIN; ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE; METHYLTRANSFERASE; RIBOSOME RNA; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIOSTASIS; ESCHERICHIA COLI; GENE FREQUENCY; GENE MUTATION; IN VITRO STUDY; ISOLATION PROCEDURE; METHYLATION; MICROBIAL ACTIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROPIONIBACTERIACEAE;

ANTI-BACTERIAL AGENTS; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; GRAM-POSITIVE COCCI; HUMANS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; PROPIONIBACTERIUM;

EID: 34250161286     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00062-07     Document Type: Article

References (41)

1. Alder, J., and B. Eisenstein. 2004. The advantage of bactericidal drugs in the treatment of infection. Curr. Infect. Dis. Rep. 6:251-253.
2. Bojar, R. A., K. T. Holland, and W. J. Cunliffe. 1991. The in-vitro antimicrobial effects of azelaic acid upon Propionibacterium acnes strain P37. J. Antimicrob. Chemother. 28:843-853.
3. Brakstad, O. G., K. Aasbakk, and J. A. Maeland. 1992. Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene. J. Clin. Microbiol. 30:1654-1660.
4. Chiller, K., B. A. Selkin, and G. J. Murakawa. 2001. Skin microflora and bacterial infections of the skin. J. Investig. Dermatol. Symp. Proc. 6:170-174.
5. Coudron, P. E., and C. W. Stratton. 1995. Use of time-kill methodology to assess antimicrobial combinations against metronidazole- susceptible and metronidazole-resistant strains of Helicobacter pylori. Antimicrob. Agents Chemother. 39:2641-2644.
6. Credito, K. L., and P. C. Appelbaum. 2004. Activity of OPT-80, a novel macrocycle, compared with those of eight other agents against selected anaerobic species. Antimicrob. Agents Chemother. 48:4430-4434.
7. Cunliffe, W. J. 1986. Acne and unemployment. Br. J. Dermatol. 115:386.
8. Davies, B. I. 1990. The importance of the geometric mean MIC. J. Antimicrob. Chemother. 25:471-472.
9. Deshpande, L., P. R. Rhomberg, T. R. Fritsche, H. S. Sader, and R. N. Jones. 2004. Bactericidal activity of BAL9141, a novel parenteral cephalosporin against contemporary gram-positive and gram-negative isolates. Diagn. Microbiol. Infect. Dis. 50:73-75.
10. Eady, E. A. 1998. Bacterial resistance in acne. Dermatology 196:59-66.
11. Eady, E. A., J. H. Cove, and A. M. Layton. 2003. Is antibiotic resistance in cutaneous propionibacteria clinically relevant?: implications of resistance for acne patients and prescribers. Am. J. Clin. Dermatol. 4:813-831.
12. Eady, E. A., M. Gloor, and J. J. Leyden. 2003. Propionibacterium acnes resistance: a world-wide problem. Dermatology 206:54-56.
13. Graham, G. M., M. D. Farrar, J. E. Cruse-Sawyer, K. T. Holland, and E. Ingham. 2004. Proinflammatory cytokine production by human keratinocytes stimulated with Propionibacterium acnes and P. acnes GroEL. Br. J. Dermatol. 150:421-428.
14. Gupta, M. A., A. K. Gupta, N. J. Schork, C. N. Ellis, and J. J. Voorhees. 1990. Psychiatric aspects of the treatment of mild to moderate facial acne. Some preliminary observations. Int. J. Dermatol. 29:719-721.
15. Gupta, M. A., and A. K. Gupta. 1998. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br. J. Dermatol. 139:846-850.
16. Kellenberger, L., V. Bitsch, P. Guerry, S. Heller, S. Shapiro, M. Wiederkehr, X.-P. Wu, and L. Xu. 2006. BAL19403: synthesis and in vitro antibacterial activity of a novel macrolide. Abstr. 46th Intersci. Conf. Antimicrob. Agents Chemother., abstr. F1-1977.
17. Kersey, P., M. Sussman, and M. Dahl. 1980. Delayed skin test reactivity to Propionibacterium acnes correlates with severity of inflammation in acne vulgaris. Br. J. Dermatol. 103:651-655.
18. Kishishita, M., T. Ushijima, Y. Ozaki, and V. Ito. 1979. Biotyping of Propionibacterium acnes isolated from normal human facial skin. Appl. Environ. Microbiol. 38:585-589.
19. Lasek, R. J., and M. M. Chren. 1998. Acne vulgaris and the quality of life of adult dermatology patients. Arch. Dermatol. 134:454-458.
20. Leyden, J. J., K. J. McGinley, S. Cavalieri, G. F. Webster, O. H. Mills, and A. M. Kligman. 1983. Propionibacterium acnes resistance to antibiotics in acne patients. J. Am. Acad. Dermatol. 8:41-45.
21. Martínez-Martínez, L., P. Joyanes, A. I. Suárez, and E. J. Perea. 2001. Activities of gemifloxacin and five other antimicrobial agents against Listeria monocytogenes and coryneform bacteria isolated from clinical samples. Antimicrob. Agents Chemother. 45:2390-2392.
22. Mathews, S., E. Spieser, F. Bachmann, and J. Heim. 2006. BAL19403: a novel macrolide with potent anti-inflammatory properties. Abstr. 46th Intersci. Conf. Antimicrob. Agents Chemother., abstr. F1-1978.
23. Miller, T. L., and M. J. Wolin. 1974. A serum bottle modification of the Hungate technique for cultivating obligate anaerobes. Appl. Microbiol. 27:985-987.
24. National Committee for Clinical Laboratory Standards. 1999. Methods for determining bactericidal activity of antimicrobial agents. Approved guidelines, M26-A. National Committee for Clinical Laboratory Standards, Wayne, PA.
25. National Committee for Clinical Laboratory Standards. 2001. Methods for antimicrobial susceptibility testing of anaerobic bacteria, 5th ed.; approved standard M11-A5. National Committee for Clinical Laboratory Standards, Wayne, PA.
26. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed.; approved standard M7-A6. National Committee for Clinical Laboratory Standards, Wayne, PA.
27. Noble, W. C. 1999. Ecology and host resistance in relation to skin disease, p. 184-191. In I. M. Freedberg, A. Z. Eisen, K. Wolf, K. F. Austen, L. A. Goldsmith, S. I. Katz, and T. B. Fitzpatrick (ed.), Fitzpatrick's dermatology in general medicine, vol. 1, 5th ed. McGraw-Hill Professional Publishing, New York, NY.
28. Oprica, C., L. Emtestam, J. Lapins, E. Borglund, F. Nyberg, K. Stenlund, L. Lundeberg, E. Sillerström, and C. E. Nord. 2004. Antibiotic-resistant Propionibacterium acnes on the skin of patients with moderate to severe acne in Stockholm. Anaerobe 10:155-164.
29. Oprica, C., C. E. Nord, and the ESCMID Study Group on Antimicrobial Resistance in Anaerobic Bacteria. 2005. European surveillance study on the antibiotic susceptibility of Propionibacterium acnes. Clin. Microbiol. Infect. 11:204-213.
30. B) resistance in cutaneous propionibacteria from six European cities. J. Antimicrob. Chemother. 49:165-168.
31. Ross, J. I., E. A. Eady, J. H. Cove, and W. J. Cunliffe. 1998. 16S rRNA mutation associated with tetracycline resistance in a gram-positive bacterium. Antimicrob. Agents Chemother. 42:1702-1705.
32. Ross, J. I., E. A. Eady, J. H. Cove, C. E. Jones, A. H. Ratyal, Y. W. Miller, S. Vyakrnam, and W. J. Cunliffe. 1997. Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA. Antimicrob. Agents Chemother. 41:1162-1165.
33. Ross, J. I., E. A. Eady, J. H. Cove, A. H. Ratyal, and W. J. Cunliffe. 1998. Resistance to erythromycin and clindamycin in cutaneous propionibacteria is associated with mutations in 23S rRNA. Dermatology 196:69-70.
34. Ross, J. I., A. M. Snelling, E. Carnegie, P. Coates, W. J. Cunliffe, V. Bettoli, G. Tosti, A. Katsambas, J. I. Galvan Peréz Del Pulgar, O. Rollman, L. Török, E. A. Eady, and J. H. Cove. 2003. Antibiotic-resistant acne: lessons from Europe. Br. J. Dermatol. 148:467-478.
35. Ross, J. I., A. M. Snelling, E. A. Eady, J. H. Cove, W. J. Cunliffe, J. J. Leyden, P. Collignon, B. Dréno, A. Reynaud, J. Fluhr, and S. Oshima. 2001. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia. Br. J. Dermatol. 144:339-346.
36. Sabath, L. D., N. Wheeler, M. Laverdiere, D. Blazevic, and B. J. Wilkinson. 1977. A new type of penicillin resistance of Staphylococcus aureus. Lancet i:443-447.
37. Smith, R. F. 1969. Characterization of human cutaneous lipophilic diphtheroids. J. Gen. Microbiol. 55:433-443.
38. Theron, M. M., M. N. J. van Rensburg, and L. J. Chalkley. 2004. Nitroimidazole resistance genes (nimB) in anaerobic gram-positive cocci (previously Peptostreptococcus spp.). J. Antimicrob. Chemother. 54:240-242.
39. Van den Velde, S., K. Lagrou, K. Desmet, G. Wauters, and J. Verhaegen. 2006. Species identification of corynebacteria by cellular fatty acid analysis. Diagn. Microbiol. Infect. Dis. 54:99-104.
40. Webster, G. F. 1995. Inflammation in acne vulgaris. J. Am. Acad. Dermatol. 33:247-253.
41. Yamakawa, T., J. Mitsuyama, and K. Hayashi. 2002. In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone. J. Antimicrob. Chemother. 49:455-465.